Table 2.
Analytes included in the study. All assays were performed using reagents specific for the Abbott ARCHITECT c16000 analyzer
| Analyte | Male | Female | Male and Female |
|---|---|---|---|
| Albumin BCG (g/L) 1 | 38.1 – 49.4 | 37.6 – 48.6 | 37.9 – 48.9 |
| ALT (U/L) 1 | 8-57 | 7 – 39* | 7-49 |
| Alk Phos (U/L) 2 | 47 – 168* | 36-105 | 39-142 |
| Amylase (U/L) 1 | 38.8 – 135 | 36.6 – 118 | 38.3 – 122 |
| AST(U/L) 1 | 12 – 47* | 11 – 26* | 11 – 33* |
| Calcium (mmol/L) 1 | 2.19 – 2.49 | 2.19 – 2.51 | 2.19 – 2.50 |
| Cholesterol (mmol/L) NA | 2.99 – 6.69 | 3.04 – 6.44 | 3.01 – 6.61 |
| Chloride (mmol/L) 1 | 102 – 109 | 103 – 109 | 102 – 109 |
| CK (U/L) 2 | 65 – 270 | 37 – 173 | 44-253 |
| CK-MB (U/L) 1 | 8 – 31* | 7-23 | 7 – 28 |
| Creatinine, alkaline picrate Jaffe (µmol/L) 2 | 69-110 | 55-83 | 57-105 |
| D-HDL (mmol/L) NA | 0.78 – 1.88 | 0.86 – 1.89 | 0.80 – 1.89 |
| Iron (µmol/L) 2 | 8.5 – 37.8 | 5.9 – 31.1 | 7.1 – 35.6 |
| GGT (U/L) 2 | 11-79 | 9 – 57* | 9-76 |
| K (mmol/L) 1 | 3.5 – 5.2 | 3.6 – 5.2 | 3.6 – 5.2 |
| LD (U/L) 1 | 130-247 | 128 – 242* | 128-245 |
| Mg (mmol/L) 1 | 0.82 – 1.15 | 0.77 – 1.13* | 0.80 – 1.14 |
| Na (mmol/L) 1 | 137-144 | 137-143 | 137-143 |
| Phosphorus (mmol/L) 1 | 0.75 – 1.36 | 0.77 – 1.41 | 0.76 – 1.40 |
| T-Bili (µmol/L) 1 | 4.5 – 22.8 | 3.7 – 16.3 | 4.0 – 21.0 |
| Total Protein (g/L) 1 | 62.9 – 79.3 | 63.5 – 79.0 | 63.0 – 79.1 |
| Triglycerides (mmol/L) NA | 0.52 – 4.96 | 0.48 – 3.14 | 0.50 – 4.29 |
| TIBC (umol/L) 2 | 42.6 – 70.6 | 45.3 – 77.5 | 43.7 – 74.3 |
| Urea (BUN) (mmol/L) 1 | 3.2 – 7.5 | 2.3 – 6.4 | 2.7 – 7.2 |
| Uric Acid (mmol/L) 2 | 0.22 – 0.55 | 0.16 – 0.37 | 0.17 – 0.52 |
1 Laboratory uses the combined male and female reference interval
2 Laboratory uses the gender specific reference intervals for male and female
NA Reference intervals not applicable for Chol, D-HDL, and Trig as the laboratory uses the NCEP Adult Treatment Panel III Report cutoff values
* Confidence ratio exceeds 0.30